Mason Immunotherapy in the News

Dr. Mason's work has appeared in the news. Here are some recent articles:

Dog cancer research advances pursuit of drugs for humans and canines

Washington Post — Tuesday, Jun 20, 2023
Dr. Nicola Mason was interviewed about her clinical trials using listeria.
A promising potential treatment for osteosarcoma

dvm360 — Friday, May 5, 2023
Dr. Nicola Mason talks about her immunotherapy research that may help both dogs and children.
How a dog’s life may change the course of cancer in people

Boston Globe — Friday, Dec 9, 2022
Dr. Nicola Mason was interviewed about her clinical trials using listeria.
Exploring new treatment options for a devastating cancer

AAHA — Wednesday, Nov 23, 2022
Dr. Nicola Mason talks about a new clinical trial looking at the safety and efficacy of copanlisib to treat metastatic splenic hemangiosarcoma.
Cancer treatments for dogs could also lead to breakthroughs for humans

60 Minutes — Sunday, Nov 27, 2022
Dr. Nicola Mason was interviewed about her role in leading clinical trials evaluating a novel Listeria-based vaccine to treat pet dogs with osteosarcoma, a common canine bone cancer.